A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)
Because we design our programs to meet a variety of lifestyle needs, we also offer virtual weight loss programs and a flexible lifestyle program to help you meet your goals in a way that works best for you
FDAs Warning Letter to 503A pharmacy Boothwyn Pharmacy, LLC, issued on January 16, but not published until February 10, identifies violations for the pharmacys GLP-1 and other compounded products concerning insanitary conditions and strength, quality, or purity noncompliance with the compounded products stated contents all fair game under the FD&C Act
LGC Limited
By moving beyond generic advice and utilizing advanced GLP-1 therapy, we provide a clinical framework designed to reset the bodys metabolic signals, ensuring that your weight loss journey is as efficient as it is sustainable
This obvious fact has serious implications that many prescribers gloss over